Promotion

mRNA 15% OFF + Buy NTPs, get DNase I

ARCA, 100mM Sodium Salt Solution

N7-Methyl-3'-O-Methyl-Guanosine-5'-Triphosphate-5'-Guanosine, 100mM sodium salt solution
Catalog No. ON-121
CAS No. 400806-46-4
Purity HPLC≥95.0%
Molecular Formula C22H31N10O18P3 (free acid)
Molecular Weight 817.4 (free acid)
Storage Condition -20℃

ARCA, 100mM Sodium Salt Solution

N7-Methyl-3'-O-Methyl-Guanosine-5'-Triphosphate-5'-Guanosine, 100mM sodium salt solution
Grade
Amount/Package: 0.1mL / centrifuge tube
SKU: ON-121-UL100-P
Unit price:
$125.00

Price

$125.00
Taxes, discounts and Shipping calculated at checkout.
This variant is unavailable. Contact us if you have particular requirements.
Checkout

This Variant only supports customization. Please click the inquire button to submit a custom request.

Price/Order Inquiry

Shipping notes

Products on this site:
Currently ships to US and Canada.
For shipping worldwide, please contact us.
Order fulfillment: within 2 business days, if available.
US: 2-8 days (from CA by FedEx).
Canada: 5-10 days (excludes customs delays).

Details

Anti Reverse Cap Analog (ARCA) is a chemically modified cap analogue that is incorporated into mRNA through co-transcription to ensure that the 5' end of the mRNA forms the correct cap structure, which is a necessary condition for ribosome recognition and translation initiation. Its molecular formula is 3'-OMe-m7G(5')ppp(5')G.


Applications

Significantly enhance the translation efficiency of mRNA.

It can resist degradation by nucleases, prolong the half-life and stability of mRNA within the cell, thereby increasing the protein expression level. ARCA prevents the reverse insertion of the cap structure through chemical modification, ensuring maximum translation efficiency.


Features and Benefits

  • High capping efficiency
  • Minimized GTP competition
  • Improved translation efficiency
  • Resistance to decapping enzymes
  • Compatibility with delivery systems
  • Scalable one-post synthesis and cost-effectiveness

Specifications

  • Catalog No.
    ON-121
  • CAS No.
    400806-46-4
  • SMILES
    O=C1C(N=CN2[C@H]3[C@H](O)[C@H](O)[C@@H](COP([O-])(OP(OP(OC[C@H]4O[C@@H](N(C=[N+]5C)C6=C5C(NC(N)=N6)=O)[C@H](O)[C@@H]4OC)([O-])=O)([O-])=O)=O)O3)=C2N=C(N)N1.[3Na+]
  • Molecular Formula
    C22H31N10O18P3 (free acid)
  • Molecular Weight
    817.4 (free acid)
  • Appearance
    Clear colorless to faint yellow solution
  • Purity
    HPLC≥95.0%
  • Storage Condition
    -20℃

Documentation

Anti Reverse Cap Analog (ARCA) is a chemically modified cap analogue that is incorporated into mRNA through co-transcription to ensure that the 5' end of the mRNA forms the correct cap structure, which is a necessary condition for ribosome recognition and translation initiation. Its molecular formula is 3'-OMe-m7G(5')ppp(5')G.


Applications

Significantly enhance the translation efficiency of mRNA.

It can resist degradation by nucleases, prolong the half-life and stability of mRNA within the cell, thereby increasing the protein expression level. ARCA prevents the reverse insertion of the cap structure through chemical modification, ensuring maximum translation efficiency.


Features and Benefits

  • High capping efficiency
  • Minimized GTP competition
  • Improved translation efficiency
  • Resistance to decapping enzymes
  • Compatibility with delivery systems
  • Scalable one-post synthesis and cost-effectiveness

Why choose Hongene?

Trusted Partner in Nucleic Acid

Integrated Supply & Commercial Scale

With nearly 30 years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.

Proprietary Technology & IP

Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.

Rigorous Quality

We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.

Manufacturing Scalability

Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.

Global Business Network

Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.

Global Business Distribution
40+
Countries & Regions
3000≈
Global Clients
54000+L
Annual NTP Production
58+t
Annual Amidites Production